JM

Cascade BioSciences Inc.

TSX: CSBX

Mid-cap oncology developer. Lead candidate CSB-204 in Phase II. Disclosure quality has deteriorated across the last two reporting cycles.

OverviewFlagsFilingsContradictionsRisksNetworkEnforcementInsider trades

Entity resolution against enforcement registry

Checked 8 named individuals · 0 matched · 8 clean.

No enforcement history matched for any named individual.